Our novel approach restores KCC2 function by modulating the BDNF-TrkB interaction-mediated KCC2 degradation in newborn mice with seizures caused by ischemia, providing a foundation for further studies to explore the link between neonatal seizures, pharmacoresistance, and the TrkB pathway. Here, NTRK2 is linked to ischemia.